Targets for Alzheimer's disease: lessons learnt from flies

Abstract

Neurodegenerative diseases, including Alzheimer's disease (AD), are a major focus of the pharmaceutical industry. Recently, human genetic analyses have aided in the successful identification of a handful of genes responsible for genetically inherited forms of AD, but our understanding of basic mechanisms that lead to the more common sporadic forms of this disease is still limited.